NO951240D0 - Anvendelse av IL-10 til forebyggelse eller behandling av insulinavhengig diabetes mellitus - Google Patents

Anvendelse av IL-10 til forebyggelse eller behandling av insulinavhengig diabetes mellitus

Info

Publication number
NO951240D0
NO951240D0 NO951240A NO951240A NO951240D0 NO 951240 D0 NO951240 D0 NO 951240D0 NO 951240 A NO951240 A NO 951240A NO 951240 A NO951240 A NO 951240A NO 951240 D0 NO951240 D0 NO 951240D0
Authority
NO
Norway
Prior art keywords
diabetes mellitus
dependent diabetes
prevent
treat insulin
insulin
Prior art date
Application number
NO951240A
Other languages
English (en)
Other versions
NO951240L (no
Inventor
Martha W Bond
Kevin W Moore
Kenneth Pennline
Paul J M Vieira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO951240D0 publication Critical patent/NO951240D0/no
Publication of NO951240L publication Critical patent/NO951240L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO951240A 1992-10-01 1995-03-30 Anvendelse av IL-10 til forebyggelse eller behandling av insulinavhengig diabetes mellitus NO951240L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95552392A 1992-10-01 1992-10-01
PCT/US1993/009030 WO1994008606A1 (en) 1992-10-01 1993-09-28 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus

Publications (2)

Publication Number Publication Date
NO951240D0 true NO951240D0 (no) 1995-03-30
NO951240L NO951240L (no) 1995-05-30

Family

ID=25496932

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951240A NO951240L (no) 1992-10-01 1995-03-30 Anvendelse av IL-10 til forebyggelse eller behandling av insulinavhengig diabetes mellitus

Country Status (24)

Country Link
EP (1) EP0662837B1 (no)
JP (1) JP2739770B2 (no)
KR (1) KR0166663B1 (no)
CN (1) CN1093598A (no)
AT (1) ATE180168T1 (no)
AU (1) AU689448B2 (no)
CA (1) CA2145863A1 (no)
CZ (1) CZ286866B6 (no)
DE (1) DE69325029T2 (no)
DK (1) DK0662837T3 (no)
ES (1) ES2131122T3 (no)
FI (1) FI951511A (no)
GR (1) GR3030269T3 (no)
HK (1) HK1008812A1 (no)
HU (1) HU217871B (no)
IL (1) IL107153A (no)
MX (1) MX9306043A (no)
MY (1) MY111543A (no)
NO (1) NO951240L (no)
SG (1) SG48733A1 (no)
SK (1) SK281806B6 (no)
TW (1) TW336172B (no)
WO (1) WO1994008606A1 (no)
ZA (1) ZA937244B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0752879A4 (en) * 1994-04-08 1999-07-21 Brigham & Womens Hospital TREATMENT OF AUTOIMMUNE DISEASES WITH TOLERANCE INDUCING AGENTS AND / OR ORAL TH2-ENHANCING CYTOKINES
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
JPH11501506A (ja) * 1994-12-12 1999-02-09 ベス イスラエル デアコネス メディカル センター キメラ型サイトカインおよびその利用
WO1997005895A1 (en) * 1995-08-07 1997-02-20 Schering Corporation Treatment of ocular inflammatory conditions with interleukin-10
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
EP0845994A1 (en) * 1995-08-09 1998-06-10 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US5939069A (en) 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
WO1999006059A2 (en) * 1997-07-30 1999-02-11 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
WO1999019301A1 (fr) * 1997-10-14 1999-04-22 Yoshitomi Pharmaceutical Industries, Ltd. Composes de piperazine et utilisation medicale desdits composes
JP2002289768A (ja) 2000-07-17 2002-10-04 Rohm Co Ltd 半導体装置およびその製法
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
EP2937088B1 (en) 2012-12-21 2020-11-18 Tokushima University Composition having tissue repairing activity and utilization thereof
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
WO2017181143A1 (en) 2016-04-15 2017-10-19 Generon (Shanghai) Corporation, Ltd. Use of il-22 in treating necrotizing enterocolitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
ES2131122T3 (es) 1999-07-16
AU689448B2 (en) 1998-04-02
TW336172B (en) 1998-07-11
AU5163593A (en) 1994-05-09
SG48733A1 (en) 1998-05-18
KR0166663B1 (en) 1999-01-15
CA2145863A1 (en) 1994-04-28
KR950703353A (ko) 1995-09-20
HU217871B (hu) 2000-04-28
SK281806B6 (sk) 2001-08-06
DE69325029T2 (de) 1999-10-07
IL107153A0 (en) 1993-12-28
MY111543A (en) 2000-08-30
IL107153A (en) 2000-07-16
FI951511A0 (fi) 1995-03-30
DK0662837T3 (da) 1999-11-08
CZ80495A3 (en) 1996-01-17
JPH07507567A (ja) 1995-08-24
ATE180168T1 (de) 1999-06-15
GR3030269T3 (en) 1999-08-31
ZA937244B (en) 1994-06-27
FI951511A (fi) 1995-03-30
HU9500933D0 (en) 1995-05-29
JP2739770B2 (ja) 1998-04-15
CZ286866B6 (en) 2000-07-12
HUT71421A (en) 1995-11-28
EP0662837A1 (en) 1995-07-19
WO1994008606A1 (en) 1994-04-28
HK1008812A1 (en) 1999-05-21
NO951240L (no) 1995-05-30
MX9306043A (es) 1994-04-29
CN1093598A (zh) 1994-10-19
DE69325029D1 (de) 1999-06-24
EP0662837B1 (en) 1999-05-19
SK42395A3 (en) 1997-01-08

Similar Documents

Publication Publication Date Title
NO951240D0 (no) Anvendelse av IL-10 til forebyggelse eller behandling av insulinavhengig diabetes mellitus
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
NL7900871A (nl) Werkwijze voor de therapeutische behandeling van hyperlipidemie en hyperlipiproteinemie.
DE69830751D1 (de) Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen
NO940266L (no) Indre strålingsskade
WO1997003188A3 (de) Verwendung von mp52 oder mp121 zur behandlung und prävention von erkrankungen des nervensystems
PL298890A1 (en) Sulfonylobenzyl substituted benzo- and pyridopyridones, method of obtaining sames and therapeutic agents containing them
NO881109D0 (no) Middel til innsekt- og middbeskyttelse.
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
ATE357914T1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
DE68907569T2 (de) Mittel zur Behandlung oder Vorbeugung von Aids.
DK0869785T3 (da) 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus
DE59308900D1 (de) (-)-metrifonat enthaltendes arzneimittel
ATE36333T1 (de) Hydantoin enthaltende therapeutische mittel.
DE69103294T2 (de) Verwendung der 3-Oxygermylpropionsäure zur Behandlung und Prävention von Diabetes verursacht durch Autoimmunkrankheiten.
DE68906028T2 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
NO905643D0 (no) Fremgangsmaate for behandling av manganslam.
JPS5399332A (en) Antibacterials for animals
NO882499D0 (no) Apparat for personlig beskyttelse mot virkningen av jordstraaler.
IT8709365A0 (it) Dispositivo per il recupero dipersone infortunate da crepacci o analoghi luoghi di difficile accesso ai soccorsi.
CS193877B1 (en) Method of treatment the hydrolysate of the agricultural refuse substances,notably the excrements
RO65968A2 (ro) Medicament destinat tratamentului gastritelor,gastroduodenitelor si ulcerelor gastroduodenale
ES517325A0 (es) Procedimiento de tratamiento de substancias proteinicas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application